One Health Group PLC (AIM: OHGR) has quietly become one of the few small-cap ways to invest directly in the effort to clear England's elective surgery backlog. The Sheffield-based provider of NHS-funded operations reported its fifth consecutive year of growth on 6 July 2026, with Revenue up 11% to £31.6m and profit before tax up 78% to £2.7m for the year to 31 March 2026, alongside a rising Dividend and £11.1m of cash.

The bigger question is whether it can turn a capital-light outsourcing model into something more ambitious. Construction of its first owned surgical hub in Scunthorpe, costed at £8m to £9m, is under way, and three long-term NHS contracts now underpin roughly 80% of activity. Valued at around £35m, OHGR is a small company attached to a very large national problem.

Full-year results: profit before tax up 78% as capacity expands

The most important recent announcement is the results for the year ended 31 March 2026, published on 6 July 2026. Revenue rose 11% to £31.6m from £28.4m, Gross Profit climbed 21% to £6.5m as the gross Margin widened by 160 basis points to 20.5%, and adjusted EBITDA increased 28% to £2.6m. Operating profit was £2.4m against £1.5m a year earlier, when £0.4m of AIM admission costs weighed, and profit before tax reached £2.7m, helped by £384,000 of interest income on cash. Basic Earnings Per Share rose 50% to 15.18p.

The operating statistics explain the financials. New NHS patient referrals grew 11% to 18,931, consultations rose 20% to 50,774 and surgical procedures increased 15% to 8,113. Consultants (excluding anaesthetists) expanded from 80 to 88, outreach clinics from 37 to 40 and surgical operating facilities from 10 to 14.

Chief executive Adam Binns said: "2026 marked our fifth consecutive year of growth. We have ambitious prospects, which have been further accelerated by the successful AIM IPO completed in March 2025." Chairman Derek Bickerstaff cited "another double digit increase in all our main indices for growth".

EBITDA came in ahead of the £2.3m consensus cited in the April 2026 trading update.

What One Health does

Founded in 2004, One Health Group provides elective surgical care to NHS patients, free at the point of use, under the NHS Patient Choice pathway. GP-referred patients can choose One Health (LSE:OHGR) rather than wait for their local trust; the company sees them in 40 community outreach clinics and operates using theatre capacity at independent hospitals and NHS facilities. It is paid by the NHS per patient, and roughly 40% of patients progress to surgery.

Its specialties are orthopaedics, spinal surgery, general surgery, gynaecology and urology. It is concentrated in Yorkshire, Derbyshire, Nottinghamshire, Lincolnshire and Leicestershire, and in FY26 earned revenue from 29 of England's 42 integrated care boards plus six direct NHS trust contracts.

The strategic shift now under way is towards owning capacity. Previously quoted on Aquis, the company raised £7.8m gross at 180p per share and moved to AIM on 20 March 2025, primarily to fund its first surgical hub. Construction began in Scunthorpe in March 2026, targeting a one-year build and an opening early in FY2027/28. At admission the company said a hub could generate £6m to £9m of annual revenue and be profitable in its first full year.

Financial position: cash-rich, lightly indebted, dividend rising

At 31 March 2026 One Health (LSE:OHGR) held £11.1m of cash, marginally down from £11.4m despite £1.9m of Capital expenditure, chiefly the Scunthorpe land and development, and £838,000 of dividends paid. Borrowings were just £1.1m. Operating cash generation was £2.8m, giving £2.0m of net cash from operations after tax and working capital, and net Assets stood at £13.0m.

The board has proposed a final dividend of 4.2p, taking the FY26 total to 6.3p from 6.2p, payable around 18 September subject to AGM approval on 11 September. Adjusted EBITDA of £2.6m on £31.6m of revenue is an 8% margin, a reminder that the outsourced model is high-volume but relatively thin.

Catalysts: hub construction, contract certainty and NHS policy

The Scunthorpe hub is the biggest lever. The company says it "has the potential to materially enhance the Group's revenue and profitability", and further hub locations are being assessed.

Contract visibility has improved markedly. On 7 April 2026 One Health announced that Sheffield Teaching Hospitals, a customer for more than a decade on annual renewals, had signed a three-year, multi-million-pound agreement. With renewals from the Lincolnshire and South Yorkshire integrated care boards, these three contracts cover about 80% of group activity.

Policy is also supportive. The government's 10-Year Health Plan for England, published in July 2025, and its target of treating 92% of patients within 18 weeks by March 2029 both rely on additional elective capacity, while the NHS waiting list still stood at 7.1 million in March 2026. Heather Craven, appointed part-time chief financial officer on 8 April 2026, brings NHS trust and AIM experience. The AGM statement and the half-year trading update, which last year came in late October, are the next scheduled data points.

Risks investors should watch

One Health depends on a single customer, the NHS, and its revenue is governed by national tariffs and commissioning decisions it does not control. Tariff Deflation or a policy move away from independent-sector provision would hit the Business directly, and around 80% of activity sits in just three contracts.

The surgical hub is a step change in capital intensity and execution risk for a company whose annual EBITDA is under £3m. An £8m to £9m build against £11.1m of cash leaves limited headroom for overruns, delays or a slow ramp-up, and the hub's projected £6m to £9m of annual revenue is a company estimate rather than contracted income. Growth also relies on recruiting consultants and securing theatre time at third-party hospitals. Margins remain modest, and the shares are relatively illiquid: the chairman holds 32.2% and the free float is about 41%.

Outlook

One Health Group enters its 2027 financial year with record activity, negligible debt, a growing dividend and multi-year visibility on most of its revenue. The board expects continued organic growth from rising referrals and an expanding surgeon base, and says it is "well-funded" to deliver the hub programme.

What to monitor is whether the Scunthorpe hub is delivered on time and on budget, whether its Economics match the company's projections, and how quickly a second site follows. Half-year trading in late 2026 will show whether double-digit growth is sustainable. In a sector where policy tailwinds are strong but margins are thin, the transition from renting capacity to owning it will determine whether OHGR remains a steady small-cap or becomes something larger.